Literature DB >> 6929699

A variant form of hypergranular promyelocytic leukaemia (M3)

J M Bennett, D Catovsky, M T Daniel, G Flandrin, D A Galton, H R Gralnick, C Sultan.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6929699     DOI： 10.1111/j.1365-2141.1980.tb01195.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  18 in total

1.  Is the practice of haematology evidence based? II. Evidence based morphological diagnosis.

Authors:  M M Reid; M J Galloway
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

2.  Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Authors:  Jae H Park; Baozhen Qiao; Katherine S Panageas; Maria J Schymura; Joseph G Jurcic; Todd L Rosenblat; Jessica K Altman; Dan Douer; Jacob M Rowe; Martin S Tallman
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

3.  Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).

Authors:  Inaam Bashir Hassan; Mariam R Al Zaabi; Arif Alam; Mohammed Jawad Hashim; Martin S Tallman; Jorgen Kristensen
Journal:  Int J Hematol       Date:  2017-03-14       Impact factor: 2.490

Review 4.  Acute promyelocytic leukaemia in the all trans retinoic acid era.

Authors:  T G DeLoughery; S H Goodnight
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

5.  Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.

Authors:  Martin S Tallman; Haesook T Kim; Pau Montesinos; Frederick R Appelbaum; Javier de la Serna; John M Bennett; Guillermo Deben; Clara D Bloomfield; Jose Gonzalez; James H Feusner; Marcos Gonzalez; Robert Gallagher; Jose D Gonzalez-San Miguel; Richard A Larson; Gustavo Milone; Elisabeth Paietta; Chelo Rayon; Jacob M Rowe; Concha Rivas; Charles A Schiffer; Edo Vellenga; Lois Shepherd; James L Slack; Peter H Wiernik; Cheryl L Willman; Miguel A Sanz
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

Review 6.  Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.

Authors:  Guang-Biao Zhou; Ji Zhang; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

7.  Acute promyelocytic leukaemia with hypogranular bone marrow blasts in a 16-year-old girl: diagnostic value of different genetic methods.

Authors:  W Scherulen; J Harbott; J W Janssen; J Kühl; C R Bartram
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

8.  Emerging new approaches for the treatment of acute promyelocytic leukemia.

Authors:  Jae Park; Joseph G Jurcic; Todd Rosenblat; Martin S Tallman
Journal:  Ther Adv Hematol       Date:  2011-10

9.  Chromosomes in acute nonlymphocytic leukemia.

Authors:  E L Prigogina; E W Fleischman; G P Puchkova; S A Mayakova; M A Volkova; A K Protasova; M A Frenkel
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132

Review 10.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.